Nitric oxide is a chemical compound in gas form that is sometimes used to treat infants with severe breathing problems associated with narrow blood vessels in the lungs. It works by relaxing smooth muscle to widen (dilate) blood vessels, especially in the lungs. Nitric oxide is usually used together with a breathing machine (ventilator). Inhaled nitric oxide (iNO) is recognized as a potent and selective pulmonary vasodilator that does not decrease systemic vascular tone. The therapeutic application of iNO in human was first described in 1990s. INO therapy was effective to improve oxygenation in infants with persistent pulmonary hypertension of the newborn (PPHN). Owing to its selective pulmonary vasodilator effects, iNO therapy is an important treatment for term newborns with hypoxemic respiratory failure due to PPHN. The Food and Drug Administration of the United States of America first approved iNO in 1999 for use as a medical gas to treat hypoxic respiratory failure associated with clinical or echocardiographic evidence of pulmonary hypertension in term and late preterm neonates. Thereafter, iNO therapy is clinically applied to treat PPHN in term and late preterm neonates without consensus.
The global market for Medical Inhaled Nitric Oxide is estimated to increase from US$ 1024.3 million in 2021 to reach US$ 1913.3 million by 2028, exhibiting a CAGR of 9.3% during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The main medical inhaled Nitric Oxide players include Mallinckrodt, Linde, Air Liquide, etc. The top three Medical Inhaled Nitric Oxide players account for approximately 95% of the total global market. The global medical inhaled Nitric Oxide are mainly produced in United States and Europe, they occupied for a share about 95%. North America is the largest consumer market, accounting for about 77%, followed by Europe and Asia-Pacific, with around 16% and 6% market share respectively.
Report Coverage
This latest report provides a deep insight into the global Medical Inhaled Nitric Oxide market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Medical Inhaled Nitric Oxide market, with both quantitative and qualitative data, to help readers understand how the Medical Inhaled Nitric Oxide market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions and volume in M L.
Market Segmentation:
The study segments the Medical Inhaled Nitric Oxide market and forecasts the market size by NO Concentration (800 ppm, 100 ppm and Others), by Application (Near-term and Pre-term Infants PPHN, Children and Adult ARDS and Other Diseases,), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by no concentration
800 ppm
100 ppm
Others
Segmentation by application
Near-term and Pre-term Infants PPHN
Children and Adult ARDS
Other Diseases
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
Mallinckrodt
Linde
Air Liquide
Chapter Introduction
Chapter 1: Scope of Medical Inhaled Nitric Oxide, Research Methodology, etc.
Chapter 2: Executive Summary, global Medical Inhaled Nitric Oxide market size (sales and revenue) and CAGR, Medical Inhaled Nitric Oxide market size by region, by no concentration, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Medical Inhaled Nitric Oxide sales, revenue, average price, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Medical Inhaled Nitric Oxide sales and revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, sales segment by country, by no concentration, and no concentration.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Medical Inhaled Nitric Oxide market size forecast by region, by country, by no concentration, and application.
Chapter 13: Comprehensive company profiles of the leading players, including Mallinckrodt, Linde and Air Liquide, etc.
Chapter 14: Research Findings and Conclusion